Physician profile
Michael Phillips
NPI 1043873888
$938.14
in general payments reported to CMS, 2019-2025
15 companies · $17.32 in 2025
The $17.32 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $140 · 2023: $136 · 2024: $39.21 · 2025: $17.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.65 | 2021-2025 | |
| Novo Nordisk INC | $124.41 | 2021-2022 | |
| Mylan Specialty L.P. | $120.37 | 2023 | Yupelri |
| Lilly USA, LLC | $100.87 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $92.96 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.96 | 2021-2022 | |
| Esperion Therapeutics, INC. | $35.09 | 2021 | |
| Glaxosmithkline, LLC. | $34.86 | 2021-2023 | Shingrix |
| Pfizer INC. | $22.99 | 2021 | |
| Amgen INC. | $22.25 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.74 | 2021 | |
| Amarin Pharma, INC. | $18.08 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.50 | 2021 | |
| Boston Scientific Corporation | $16.57 | 2021 | |
| Currax Pharmaceuticals LLC | $14.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.